Kazazian Asset Management’s Biogen BIIB Stock Holding History

Kazazian Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$1.62M	Hold	6,974	–	–	2.19%	16
2019 Q2	$1.63M	Buy	6,974 +1,359	+24%	+$314K	1.93%	17
2019 Q1	$1.33M	Sell	5,615 -2,721	-33%	-$857K	1.84%	17
2018 Q4	$2.51M	Sell	8,336 -3,796	-31%	-$1.21M	3.39%	10
2018 Q3	$4.29M	Sell	12,132 -9,900	-45%	-$3.41M	4.01%	6
2018 Q2	$6.39M	Buy	22,032 +7,103	+48%	+$2M	5.86%	4
2018 Q1	$4.09M	Buy	14,929 +5,700	+62%	+$1.77M	4.28%	4
2017 Q4	$2.94M	Sell	9,229 -1,272	-12%	-$408K	3%	7
2017 Q3	$3.29M	Buy	10,501 +4,500	+75%	+$1.33M	4.02%	7
2017 Q2	$1.63M	Sell	6,001 -4,199	-41%	-$1.11M	2.46%	11
2017 Q1	$2.79M	Buy	10,200 +1,800	+21%	+$509K	3.86%	7
2016 Q4	$2.38M	Buy	8,400 +5,500	+190%	+$1.63M	3.33%	10
2016 Q3	$908K	Sell	2,900 -400	-12%	-$118K	1.51%	17
2016 Q2	$798K	Buy	+3,300	New	+$870K	1.34%	18

Other funds holding BIIB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Kazazian Asset Management's BIIB Position: Q3 2019 in Review

Kazazian Asset Management held its Biogen (BIIB) position steady in Q3 2019 at 6,974 shares worth $1.62M. The position accounts for 2.19% of the portfolio, ranked #16.

Kazazian Asset Management first reported a position in BIIB in Q2 2016 and has held it in 14 quarters since. The position peaked at $6.39M in Q2 2018. 989 funds tracked by Wall St. Rank hold BIIB as of Q3 2019.

Kazazian Asset Management held 6,974 shares of Biogen worth $1.62M as of Q3 2019.
Kazazian Asset Management left its Biogen share count unchanged in Q3 2019.
Biogen made up 2.19% of Kazazian Asset Management's portfolio in Q3 2019, its #16 holding.
Kazazian Asset Management first reported a position in Biogen in Q2 2016 and has held it in 14 quarters since.
Kazazian Asset Management's Biogen position peaked at $6.39M in Q2 2018.
989 funds tracked by Wall St. Rank held Biogen as of Q3 2019.

Based on Kazazian Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.